HIGHLIGHTS
- who: . et al. from the Central South University, China have published the paper: The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma, in the Journal: (JOURNAL)
- how: These data indicated that HAMP upregulation is a potent diagnostic factor in ccRCC patients. The results showed that the most significantly enriched clusters/pathways were immune regulatory and inflammatory cytokine/chemokines as shown in Table 3 and Supplementary Figure S5.
SUMMARY
Emerging evidence indicated that aberrant iron metabolism was involved in tumorigenesis and progression, including . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.